Bryce D. Carmine

2008

In 2008, Bryce D. Carmine earned a total compensation of $6.8M as Executive Vice President and President, Lilly Bio-Medicines at Lilly Eli & Co.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,158,720
Non-Equity Incentive Plan$1,006,135
Salary$783,113
Stock Awards$3,750,000
Other$53,497
Total$6,751,465

Carmine received $3.8M in stock awards, accounting for 56% of the total pay in 2008.

Carmine also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1M in non-equity incentive plan, $783.1K in salary and $53.5K in other compensation.

Rankings

In 2008, Bryce D. Carmine's compensation ranked 520th out of 9,135 executives tracked by ExecPay. In other words, Carmine earned more than 94.3% of executives.

ClassificationRankingPercentile
All
520
out of 9,135
94th
Division
Manufacturing
174
out of 3,436
95th
Major group
Chemicals And Allied Products
33
out of 815
96th
Industry group
Drugs
21
out of 597
97th
Industry
Pharmaceutical Preparations
19
out of 408
95th
Source: SEC filing on March 8, 2010.

Carmine's colleagues

We found four more compensation records of executives who worked with Bryce D. Carmine at Lilly Eli & Co in 2008.

2008

John Lechleiter

Lilly Eli & Co

Chief Executive Officer

2008

Steven Paul

Lilly Eli & Co

Executive Vice President, Science and Technology and President, Lilly Research Laboratories

2008

Derica Rice

Lilly Eli & Co

Chief Financial Officer

2008

Robert Armitage

Lilly Eli & Co

General Counsel

You may also like